6 completed. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 2 | Completed 2 |
Follow Ixchelsis Limited: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE) IX-01 400 mg, Placebo, IX-01 800 mg - Premature Ejaculation | Phase 2 | Completed | Ixchelsis Limited | 239 | 2017-02-28 | 2019-10-07 |
| Relative Bioavailability Study of IX-01 Caplet Versus Aqueous Dispersion and Food Effect of the Caplet in Healthy Males IX-01 caplets 1600 mg (4 x 400 mg), fasted, IX-01 caplets 1600 mg (4 x 400 mg), fed, IX-01 aqueous dispersion 1600 mg (20 mL), fasted - Healthy | Phase 1 | Completed | Ixchelsis Limited | 12 | 2016-11-01 | 2017-01-13 |
| A Study of Multiple Oral Doses of IX-01 in Healthy Male Subjects Placebo, IX-01 - Healthy Volunteers | Phase 1 | Completed | Ixchelsis Limited | 24 | 2016-05-01 | 2016-11-10 |
| IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE) IX-01, Placebo - Premature Ejaculation | Phase 2 | Completed | Ixchelsis Limited | 88 | 2014-09-01 | 2020-08-17 |
| Relative Bioavailability and Food Effect Study of IX-01 Capsules in Healthy Men IX-01 - Healthy Participants | Phase 1 | Completed | Ixchelsis Limited | 12 | 2014-05-01 | 2020-08-20 |
| A Study of Multiple Oral Doses of IX-01 in Healthy Men Placebo, IX-01 - Healthy Participants | Phase 1 | Completed | Ixchelsis Limited | 48 | 2013-11-01 | 2014-09-03 |
Premature Ejaculation (2) · Coitus (1) · Sexual Dysfunction, Physiological (1)
United Kingdom (3) · United States (3) · Australia (1)